Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

107.31 +0.55 (+0.52%)
Streaming Delayed Price Updated: 2:48 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corp

< Previous 1 2 3 4 5 6 7 Next >
3 Healthcare Stocks to Buy Now: Q3 Edition
U.S. healthcare expenditures will grow by 5.6% annually, presenting a revenue tailwind for these healthcare stocks to buy now. 
Via InvestorPlace
What's Going On With Health Technology Company Masimo Shares Today?
Masimo reportedly considers an $850 million to $950 million bid for its consumer business amid active joint venture discussions while reporting strong Q2 healthcare revenue growth and record customer... 
Via Benzinga
Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Assessing Masimo: Insights From 6 Financial Analysts
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Masimo
Via Benzinga
Analyst Scoreboard: 5 Ratings For Masimo
Via Benzinga
Five Below Posts Weak Q1 Results, Joins Sprinklr, Dorian LPG And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Recap: Masimo Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
A Preview Of Masimo's Earnings
Via Benzinga
MASI Stock Earnings: Masimo Misses EPS, Beats Revenue for Q1 2024
MASI stock results show that Masimo missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. 
Via InvestorPlace
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
How's AT&T Handling Things?
We've also got a look at 3M's spinoff, gold prices, and the beef industry. 
Via The Motley Fool
Can a New CEO Fix Boeing?
We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding. 
Via The Motley Fool
Boeing's Leadership Shake-Up
And IWG CEO Mark Dixon talks with us about the global shift toward hybrid work. 
Via The Motley Fool
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches
Apple is appealing to reverse a U.S. import ban on certain Apple Watches stemming from a patent dispute with Masimo Corporation, arguing the patented Masimo wearable was theoretical and challenging the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo Breaks Out To Eight-Month High On Proposed Consumer Biz Separation
The company is considering a separation for its audio and consumer-facing businesses. 
Via Investor's Business Daily
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. 
Via Benzinga
Patient Monitoring Device Maker Masimo Contemplates Separation of Consumer Business As Activist Investor Seeks Expanded Board Presence
Politan Capital Management's Quentin Koffey prepares for a proxy battle, seeking additional Masimo Corporation board seats. With a 9% stake, Koffey aims to influence the $7.1 billion market value... 
Via Benzinga
Wall Street Set To Open Weak Lower As Tech Feels China Chill: Analyst Says Stay Bullish 'If And Until This Changes'
Major U.S. index futures edged lower on Monday, reflecting the cautious mood from last week’s close. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning. 
Via InvestorPlace
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading. 
Via Benzinga
Topics Stocks
Exposures US Equities
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Apple Watch 2.0? New Patents Hint At Expansion Beyond Health Tracking After Masimo Fiasco
Apple has been considering incorporating anemometers, bolometers, heat flux sensors, solar radiation sensors, thermometers, and water sensors into future iterations of the Apple Watch. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Tim Cook Opens Up On Apple Watch Ban, Licensing Masimo' Tech: 'We're Focused On Appeal'
Apple CEO Tim Cook has confirmed the company's plan to appeal the ban on its Apple Watch imposed in a patent dispute with Masimo, stating they have no intention of settling and will focus on the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.